Naproxen-E Mylan

Naproxen, the active ingredient in Naproxen‑E Mylan, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral formulation for oral use. It is used to relieve pain, reduce inflammation, and lower fever in adults with conditions such as osteoarthritis, rheumatoid arthritis, and short‑term musculoskeletal pain. GNH USA supplies Naproxen‑E Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces prostaglandin‑mediated inflammation and pain.

- Pain relief: provides analgesia for mild to moderate acute or chronic pain. - Osteoarthritis: decreases joint pain and improves mobility. - Rheumatoid arthritis: alleviates inflammatory joint symptoms. - Fever: lowers elevated body temperature. - Musculoskeletal injuries: diminishes pain and swelling associated with sprains or strains.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset: dyspepsia, nausea, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Rash: mild skin irritation or erythema.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Renal impairment: reduced kidney function or acute kidney injury. - Cardiovascular events: increased risk of myocardial infarction or stroke. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and follow safe‑use guidelines.

- Assess renal function: monitor kidney parameters in patients with existing renal disease. - Evaluate gastrointestinal risk: avoid in individuals with active peptic ulcer disease or a history of serious GI bleeding. - Cardiovascular caution: use cautiously in patients with heart failure, hypertension, or known cardiovascular disease. - Pregnancy and lactation: avoid unless the potential benefit outweighs the risk to the fetus or infant. - Concomitant NSAIDs: do not combine with other NSAIDs or aspirin without medical supervision. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original packaging.

Naproxen can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity. - ACE inhibitors or ARBs: may diminish renal function when combined.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: heightened bleeding tendency. - Diuretics: potential impact on renal clearance and electrolyte balance.